(NASDAQ: MBOT) Microbot Medical's forecast annual revenue growth rate of 500.05% is forecast to beat the US Medical Instruments & Supplies industry's average forecast revenue growth rate of 9.68%, and it is also forecast to beat the US market's average forecast revenue growth rate of 13.75%.
Microbot Medical's revenue in 2026 is $105,000.On average, 5 Wall Street analysts forecast MBOT's revenue for 2026 to be $299,152,024, with the lowest MBOT revenue forecast at $190,882,364, and the highest MBOT revenue forecast at $479,556,679. On average, 4 Wall Street analysts forecast MBOT's revenue for 2027 to be $647,401,517, with the lowest MBOT revenue forecast at $572,647,093, and the highest MBOT revenue forecast at $719,335,019.
In 2028, MBOT is forecast to generate $1,633,649,455 in revenue, with the lowest revenue forecast at $1,368,617,150 and the highest revenue forecast at $1,897,069,804.